Market Capitalization

The former solar EV pioneer has completed its radical pivot, selling its solar business to management and betting its entire future on Bitcoin.

The beef giant's record R$57 billion annual revenue signals resilience, even as missed earnings and trade headwinds present complex challenges ahead.

The biotech supplier swung to profitability and positive cash flow, driven by a major cost overhaul and strong demand in its core nucleic acid business.

As Talphera preps its Q1 update, all eyes are on its breakthrough drug Niyad® and the mounting costs of bringing a potential game-changer to market.

With key clinical data on the horizon for its cancer and ALS drugs, LeonaBio adds deep financial, operational, and strategic expertise to its leadership.

With a promising cancer pipeline, Crescent Biopharma heads to key May conferences to prove its strategy against fierce competition in the bispecific and ADC markets.

The utility giant posted strong first-quarter earnings, driven by surging industrial demand, and reaffirmed its outlook amid a historic investment plan.

With $200 million in fresh capital, Quantum Leap Acquisition Corp. is hunting for a transformative company in the high-stakes world of deep technology.

Bill Ackman's ambitious Pershing Square USA fund saw a rocky NYSE launch, even as it drew high-profile global investors like Mexico's Jack Landsmanas.

While the broader housing market cools, Las Vegas's exclusive golf communities maintain their value. A new report offers a glimpse inside this resilient niche.

Singaporean engineering firm SKK Holdings pivots dramatically, acquiring Rantizo's drone assets to chase growth in agriculture and emergency response tech.

Facing steep losses, FG Nexus is exploring a merger with its CEO's other firm, a move into affordable housing that tests both strategy and shareholder trust.

With only 6% of sports science research focused on women, Gatorade's new 'Body of Science' initiative aims to finally close the critical knowledge gap.

As consumers tune out online ads, companies are rediscovering the power of human connection. Smart Circle's expansion signals a major shift back to face-to-face.

As Sachem Capital sets its Q1 earnings date, investors watch closely for signs of stability in the hard money lending market after a volatile period.

Following a year of record profits, Cipher Pharmaceuticals is renewing its share buyback program, signaling a strong belief that its stock is undervalued.

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

Aimco declares a $1.30/share liquidating distribution. Understand the 'due bills' trading and what this means for your investment as the REIT winds down.

As Kodak prepares its Q1 2026 report, investors are watching to see if its pivot to advanced materials can sustain its recent market momentum.

The rail supplier's stellar Q2 results point to surprising strength in coal, rail, and tunneling, but rising costs reveal the challenges of rapid growth.